Naomi K Tepper

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Blood pressure measurement prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:631-8. 2013
  2. doi request reprint Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:655-60. 2013
  3. doi request reprint Laboratory screening prior to initiating contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:645-9. 2013
  4. doi request reprint Use of a checklist to rule out pregnancy: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:661-5. 2013
  5. doi request reprint Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:639-44. 2013
  6. doi request reprint Physical examination prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:650-4. 2013
  7. doi request reprint Singleton preterm birth: risk factors and association with assisted reproductive technology
    Naomi K Tepper
    National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Matern Child Health J 16:807-13. 2012
  8. doi request reprint Use of intrauterine devices in women with uterine anatomic abnormalities
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Int J Gynaecol Obstet 109:52-4. 2010
  9. doi request reprint Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review
    Naomi K Tepper
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:95-101. 2010
  10. doi request reprint Use of contraceptive methods among women with endometrial hyperplasia: a systematic review
    Maura K Whiteman
    Centers for Disease Control and Prevention, Atlanta, GA 30341 3724, USA
    Contraception 82:56-63. 2010

Collaborators

Detail Information

Publications23

  1. doi request reprint Blood pressure measurement prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:631-8. 2013
    ..This review was conducted to evaluate the evidence regarding whether blood pressure should be measured prior to initiating hormonal contraceptives...
  2. doi request reprint Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:655-60. 2013
    ..This review was conducted to evaluate the evidence regarding whether an IUD should be retained or removed if a woman develops PID...
  3. doi request reprint Laboratory screening prior to initiating contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:645-9. 2013
    ..This review was conducted to evaluate the evidence regarding health outcomes among women with and without laboratory testing to identify certain medical conditions prior to initiating contraceptives...
  4. doi request reprint Use of a checklist to rule out pregnancy: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:661-5. 2013
    ..The World Health Organization has developed a list of criteria to assess pregnancy status. This review was conducted to evaluate the evidence regarding these criteria in excluding pregnancy...
  5. doi request reprint Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:639-44. 2013
    ..Women using copper intrauterine devices (IUDs) frequently experience bleeding abnormalities. This review was conducted to evaluate the evidence regarding whether hemoglobin levels should be measured prior to copper IUD insertion...
  6. doi request reprint Physical examination prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:650-4. 2013
    ..This review was conducted to evaluate the evidence regarding outcomes among women with and without physical examination prior to initiating hormonal contraceptives...
  7. doi request reprint Singleton preterm birth: risk factors and association with assisted reproductive technology
    Naomi K Tepper
    National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Matern Child Health J 16:807-13. 2012
    ..Medical conditions were associated with an increased risk for preterm birth regardless of women's ART status. Efforts to prevent preterm births should focus on reducing modifiable risk factors...
  8. doi request reprint Use of intrauterine devices in women with uterine anatomic abnormalities
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Int J Gynaecol Obstet 109:52-4. 2010
    ..To examine the evidence regarding the safety and effectiveness of intrauterine devices (IUDs) in women with uterine abnormalities...
  9. doi request reprint Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review
    Naomi K Tepper
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:95-101. 2010
    ..This systematic review examines evidence regarding the safety of contraceptive use among women with PPCM...
  10. doi request reprint Use of contraceptive methods among women with endometrial hyperplasia: a systematic review
    Maura K Whiteman
    Centers for Disease Control and Prevention, Atlanta, GA 30341 3724, USA
    Contraception 82:56-63. 2010
    ..The objective of this systematic review is to evaluate the evidence for the safety of contraceptive use among women with endometrial hyperplasia...
  11. doi request reprint Respiratory illness hospitalizations among pregnant women during influenza season, 1998-2008
    Angela Martin
    Department of Gynecology and Obstetrics, Emory University, 1648 Pierce Drive, Atlanta, GA 30322, USA
    Matern Child Health J 17:1325-31. 2013
    ..Efforts to minimize influenza morbidity, including universal vaccination and early antiviral therapy should be promoted among all pregnant women. ..
  12. doi request reprint U.S. selected practice recommendations for contraceptive use, 2013
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
    J Womens Health (Larchmt) 23:108-11. 2014
    ....
  13. doi request reprint Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States
    Maura K Whiteman
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 206:127.e1-7. 2012
    ..The purpose of this study was to estimate US rates of postpartum intrauterine device (IUD) insertion and postpartum tubal sterilization...
  14. ncbi request reprint Using a checklist to assess pregnancy in teenagers and young women
    Maura K Whiteman
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, and the Department of Gynecology and Obstetrics, Emory University, School of Medicine, Atlanta, Georgia
    Obstet Gynecol 123:777-84. 2014
    ..We examined the performance of a checklist based on criteria recommended in family planning guidance documents to assist health care providers in assessing pregnancy in a sample of U.S. teenagers and young women...
  15. doi request reprint Intrauterine device use among women with uterine fibroids: a systematic review
    Lauren B Zapata
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:41-55. 2010
    ....
  16. doi request reprint Adaptation of the World Health Organization's Selected Practice Recommendations for Contraceptive Use for the United States
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:513-6. 2013
    ..The WHO guidance includes evidence-based recommendations on common, yet sometimes complex, contraceptive management questions...
  17. doi request reprint Pregnancies after hysteroscopic sterilization: a systematic review
    Tara P Cleary
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
    Contraception 87:539-48. 2013
    ..Newer approaches to female sterilization, including hysteroscopic methods, have been approved for use in the United States since 2002. Little is known about the occurrence and timing of pregnancies after these procedures...
  18. doi request reprint Putting risk into perspective: the US medical eligibility criteria for contraceptive use
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Rev Endocr Metab Disord 12:119-25. 2011
    ..Most women, even women with medical conditions, can safely use highly effective methods of contraception and promoting their use will further efforts to reduce unintended pregnancy...
  19. doi request reprint U.S. medical eligibility criteria for contraceptive use, 2010
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    J Womens Health (Larchmt) 20:825-8. 2011
    ..Most women, even those with medical conditions, can safely use most methods of contraception...
  20. ncbi request reprint Postpartum venous thromboembolism: incidence and risk factors
    Naomi K Tepper
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion and the Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
    Obstet Gynecol 123:987-96. 2014
    ..To calculate incidence of postpartum venous thromboembolism by week after delivery and to examine potential risk factors for venous thromboembolism overall and at different times during the postpartum period...
  21. doi request reprint Intrauterine contraceptive insertion postabortion: a systematic review
    Maria W Steenland
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 84:447-64. 2011
    ..This review was conducted to evaluate the evidence regarding the safety and effectiveness of intrauterine device (IUD) insertion immediately following spontaneous or induced abortion...
  22. ncbi request reprint Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA
    Expert Rev Vaccines 11:911-21. 2012
    ..This review summarizes US and international safety data for influenza vaccines in pregnant women with an emphasis on 2009 H1N1 influenza vaccines...
  23. doi request reprint Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women
    Yenlik A Zheteyeva
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    Am J Obstet Gynecol 207:59.e1-7. 2012
    ..We sought to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) of pregnant women who received tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)...